loading
Bausch Health Companies Inc stock is traded at $8.4226, with a volume of 745.65K. It is down -0.77% in the last 24 hours and up +3.12% over the past month. Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
See More
Previous Close:
$8.48
Open:
$8.4
24h Volume:
745.65K
Relative Volume:
0.35
Market Cap:
$3.12B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-3.1904
EPS:
-2.64
Net Cash Flow:
$1.01B
1W Performance:
-10.00%
1M Performance:
+3.12%
6M Performance:
+24.30%
1Y Performance:
+21.96%
1-Day Range:
Value
$8.3619
$8.51
1-Week Range:
Value
$8.3619
$9.31
52-Week Range:
Value
$3.96
$11.46

Bausch Health Companies Inc Stock (BHC) Company Profile

Name
Name
Bausch Health Companies Inc
Name
Phone
514-744-6792
Name
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Name
Employee
20,270
Name
Twitter
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
BHC's Discussions on Twitter

Compare BHC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
BHC 8.42 3.12B 9.47B -178.00M 1.01B -2.64
ZTS 176.40 79.52B 9.15B 2.43B 2.31B 4.92
TAK 13.56 43.13B 30.27B 1.93B 3.45B 0.444
HLN 9.42 42.57B 14.26B 1.55B 0 0.3327
TEVA 16.45 18.56B 16.77B -959.00M 1.37B -2.00
VTRS 12.99 15.37B 15.24B -646.50M 1.88B 1.53

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-20-23 Upgrade Jefferies Hold → Buy
Jun-16-23 Downgrade TD Cowen Outperform → Market Perform
Jul-29-22 Downgrade RBC Capital Mkts Outperform → Sector Perform
Jul-29-22 Downgrade Truist Buy → Hold
Jul-28-22 Downgrade JP Morgan Overweight → Neutral
Jun-13-22 Resumed JP Morgan Overweight
Mar-24-21 Downgrade BofA Securities Neutral → Underperform
Feb-17-21 Upgrade RBC Capital Mkts Sector Perform → Outperform
Jan-22-21 Downgrade Piper Sandler Overweight → Neutral
Sep-17-20 Upgrade BofA Securities Underperform → Neutral
Aug-24-20 Reiterated H.C. Wainwright Buy
Jun-17-20 Reiterated H.C. Wainwright Buy
Apr-24-20 Initiated Citigroup Buy
Apr-02-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-29-20 Downgrade Wolfe Research Outperform → Peer Perform
Jan-22-20 Upgrade Wells Fargo Underweight → Equal Weight
Dec-12-19 Upgrade JP Morgan Neutral → Overweight
Dec-02-19 Initiated Goldman Neutral
Oct-25-19 Initiated Cowen Outperform
Sep-12-19 Initiated Guggenheim Buy
Aug-15-19 Upgrade TD Securities Hold → Buy
Jul-19-19 Initiated Wolfe Research Outperform
Jun-11-19 Resumed Barclays Overweight
May-13-19 Upgrade JP Morgan Underweight → Neutral
Mar-20-19 Initiated SunTrust Buy
Jan-02-19 Upgrade Piper Jaffray Neutral → Overweight
Nov-05-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-13-18 Upgrade Piper Jaffray Underweight → Neutral
View All

Bausch Health Companies Inc Stock (BHC) Latest News

pulisher
09:50 AM

US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug - Marketscreener.com

09:50 AM
pulisher
09:42 AM

Herpes Zoster Oticus Market: Company Profiles, Segment Sizes, - openPR

09:42 AM
pulisher
08:02 AM

Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis - AccessWire

08:02 AM
pulisher
08:00 AM

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS - Yahoo Finance

08:00 AM
pulisher
Nov 14, 2024

Common Warts Treatment Market Trade Analysis and Statistical - openPR

Nov 14, 2024
pulisher
Nov 14, 2024

Underactive Bladder Treatment Market Expected to Reach Huge - openPR

Nov 14, 2024
pulisher
Nov 13, 2024

Genital Herpes Treatment Market Global Share, Trends, Business - openPR

Nov 13, 2024
pulisher
Nov 13, 2024

Varicella Zoster (HHV-3) Infections Treatment Market Share, - openPR

Nov 13, 2024
pulisher
Nov 13, 2024

Vitrectomy Devices Market is expected to reach US$ 2121.3 - openPR

Nov 13, 2024
pulisher
Nov 12, 2024

22q11.2 Deletion Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Nobias Therapeutics, Zynerba Pharma, Bausch Health Americas - The Globe and Mail

Nov 12, 2024
pulisher
Nov 12, 2024

Actinic Keratosis Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyze | Bausch Health Companies, Sandoz Pharma, Athenex, Almirall, Vidac Pharma, G&E Herbal Biotech - Barchart

Nov 12, 2024
pulisher
Nov 11, 2024

Periodontal Therapeutics Market to Grow at a Promising CAGR - openPR

Nov 11, 2024
pulisher
Nov 07, 2024

Myopia and Presbyopia Treatment Market to Grow by USD 9.76 Billion from 2024-2028, as Rising Prevalence Drives Demand with AI Redefining Market LandscapeTechnavio - The Malaysian Reserve

Nov 07, 2024
pulisher
Nov 07, 2024

Are Medical Stocks Lagging Bausch Health (BHC) This Year? - MSN

Nov 07, 2024
pulisher
Nov 06, 2024

Body Contouring Treatments Market to Hit USD 2.58 Billion by 2029 with 10.0% CAGR | MarketsandMarkets™ - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Eye Health Supplements Market Trends and Growth Projections - openPR

Nov 06, 2024
pulisher
Nov 05, 2024

Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve

Nov 05, 2024
pulisher
Nov 05, 2024

189,000 Shares in Bausch Health Companies Inc. (NYSE:BHC) Bought by Intact Investment Management Inc. - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Bausch Health Companies' SWOT analysis: debt woes cloud strong Q3 stock performance - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Nov 04, 2024
pulisher
Nov 02, 2024

Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Bausch Health Companies Inc. (NYSE:BHC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Bausch Health secures $400 million loan amendment - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Bausch Health secures $400 million loan amendment By Investing.com - Investing.com UK

Nov 01, 2024
pulisher
Nov 01, 2024

Bausch Health Companies (NYSE:BHC) Price Target Raised to $11.00 at Royal Bank of Canada - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Bausch Health Companies Inc. (NYSE:BHC) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024
pulisher
Nov 01, 2024

Bausch Health Companies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Nov 01, 2024
pulisher
Nov 01, 2024

Bausch Health stock outlook lifted as RBC cites robust Q3 growth and tax benefits - Investing.com

Nov 01, 2024
pulisher
Oct 31, 2024

Traders Purchase High Volume of Bausch Health Companies Put Options (NYSE:BHC) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Toronto Stocks Drop, Canada's GDP Flat in August; Bausch Health Rises on 3Q Beat - Marketscreener.com

Oct 31, 2024
pulisher
Oct 31, 2024

Bausch Health Shares Rise on FY Outlook Upgrade, 3Q Beat - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Bausch Health Companies (NYSE:BHC) Trading 8.7% Higher on Better-Than-Expected Earnings - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Bausch Health Companies (TSE:BHC) Stock Price Up 8.4% Following Earnings Beat - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

BHCBausch Health Companies Inc. Latest Stock News & Market Updates - StockTitan

Oct 31, 2024
pulisher
Oct 31, 2024

Bausch: Q3 Earnings Snapshot - Houston Chronicle

Oct 31, 2024
pulisher
Oct 31, 2024

Bausch Health Reports Growth Amid Improved Financials - TipRanks

Oct 31, 2024
pulisher
Oct 30, 2024

Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Bausch Health Companies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 30, 2024
pulisher
Oct 30, 2024

Bausch Health Announces Third Quarter 2024 Results - AccessWire

Oct 30, 2024
pulisher
Oct 30, 2024

Gastroparesis Treatment Market Top Trends and Growth Analysis: - openPR

Oct 30, 2024
pulisher
Oct 29, 2024

Bausch Health Companies Q3 2024 Earnings Preview - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Onychomycosis Treatment Market Size, Industry Analysis, - openPR

Oct 29, 2024
pulisher
Oct 29, 2024

Actinic Keratosis Treatment Market Expected to Reach Huge - openPR

Oct 29, 2024
pulisher
Oct 29, 2024

Canada Aesthetic Devices Market Size, Share, Industry Growth, - openPR

Oct 29, 2024
pulisher
Oct 28, 2024

Bausch Health Companies Inc. and Salix Pharmaceuticals Announce Results of an Analysis of Xifaxan Monotherapy Will Be Presented During A Presidential Plenary Session of the American College of Gastroenterology 2024 Annual Scientific Meeting Taking - Marketscreener.com

Oct 28, 2024
pulisher
Oct 27, 2024

ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence - StockTitan

Oct 27, 2024
pulisher
Oct 26, 2024

TD COWEN Downgrades Bausch Health Companies (BHC) - MSN

Oct 26, 2024
pulisher
Oct 26, 2024

Deal Dispatch: TKO Buys Bull Riding, Radford Motors Is BankruptApollo Global Management (NYSE:APO), Bausch Health Companies (NYSE:BHC) - Benzinga

Oct 26, 2024
pulisher
Oct 25, 2024

Bausch Health Companies (NYSE:BHC) Lifted to "Buy" at StockNews.com - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

FY2024 EPS Estimates for TSE:BHC Lifted by Zacks Research - MarketBeat

Oct 24, 2024

Bausch Health Companies Inc Stock (BHC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$76.27
price down icon 0.72%
$13.36
price down icon 4.36%
$81.94
price down icon 1.56%
$58.71
price down icon 0.67%
$117.38
price up icon 0.26%
$12.79
price down icon 0.97%
Cap:     |  Volume (24h):